BHE, a Boston, MA-based innovative healthcare analytics company, received a $78m minority growth investment.
The round was led by Silversmith Capital Partners and Leerink Transformation Partners. In conjunction with the funding, Jeff Crisan, Managing Partner of Silversmith, and Jared Kesselheim, MD, Managing Partner of LTP, will be joining the Board of Directors of BHE.
The company intends to use the funds to accelerate the development and market expansion of its platform.
Led by Joseph Menzin, Ph.D., Founder and CEO, and Jordan Menzin, Chief Technology Officer, BHE provides a SaaS Instant Health Data (IHD) platform, a real-world evidence (RWE) analytics solution currently being used by over two dozen major life science and research organizations.
The IHD platform supports rapid analysis of over 20 disparate real-world data sets, including claims, laboratory results, electronic medical records, hospital and integrated data sources.